Incidentally Detected Malignancies in Lung Transplant Explants

Background. Active malignancy diagnosed within 5 years is an absolute contraindication for lung transplantation. In this study, we evaluated the rate of incidental malignancies detected in explanted lungs at our institution and assessed the posttransplant survival in patients with nonsmall cell lung...

Full description

Bibliographic Details
Main Authors: Dhruv A. Amratia, MD, William R. Hunt, MD, David Neujahr, MD, Srihari Veeraraghavan, MD
Format: Article
Language:English
Published: Wolters Kluwer 2019-11-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000947